In the latest trading session, 1.41 million Oscar Health Inc (NYSE:OSCR) shares changed hands as the company’s beta touched 1.74. With the company’s most recent per share price at $14.54 changed hands at -$0.28 or -1.89% at last look, the market valuation stands at $3.64B. OSCR’s current price is a discount, trading about -63.62% off its 52-week high of $23.79. The share price had its 52-week low at $12.43, which suggests the last value was 14.51% up since then.
Analysts gave the Oscar Health Inc (OSCR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.38. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended OSCR as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Oscar Health Inc’s EPS for the current quarter is expected to be 0.9.
Oscar Health Inc (NYSE:OSCR) trade information
Instantly OSCR was in red as seen in intraday trades today. With action 8.02%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 8.18%, with the 5-day performance at 8.02% in the green. However, in the 30-day time frame, Oscar Health Inc (NYSE:OSCR) is -11.72% down.
The consensus price target for the stock as assigned by Wall Street analysts is 21, meaning bulls need an upside of 30.76% from its recent market value. According to analyst projections, OSCR’s forecast low is 5 with 28 as the target high. To hit the forecast high, the stock’s price needs a -92.57% plunge from its current level, while the stock would need to tank 65.61% for it to hit the projected low.
Oscar Health Inc (OSCR) estimates and forecasts
Year-over-year growth is forecast to reach 23.79% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 2.84B. 4 analysts are of the opinion that Oscar Health Inc’s revenue for the current quarter will be 2.77B. The company’s revenue for the corresponding quarters a year ago was 2.14B and 2.22B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 32.37%. The estimates for the next quarter sales put growth at 24.90%.
The 2025 estimates are for Oscar Health Inc earnings to increase by 647.59%, but the outlook for the next 5-year period is at 160.28% per year.
Oscar Health Inc (NYSE:OSCR)’s Major holders
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.1246% or 14.18 million shares worth $224.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 6.0 shares estimated at $87.65 million under it, the former controlled 2.79% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.62% of the shares, roughly 5.63 shares worth around $82.34 million.
